ImClone Investigational Site

Ishikawa 920-8641

0 studies enrolling now · 1 studies all time

What they study most

Hepatocellular Carcinoma

Studies at this site

• A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib — Completed